Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schmeing

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Molecular Cell|April 17, 2007
The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosomeLori A Passmore, T Martin Schmeing, David Maag, et al.
Elife|February 18, 2025
Mechanisms of PP2A-Ankle2 dependent nuclear reassembly after mitosisJingjing Li, Xinyue Wang, Laia Jordana, et al.
Journal of the American Chemical Society|July 27, 2022
Structure and Function of a Dehydrating Condensation Domain in Nonribosomal Peptide BiosynthesisJon B Patteson, Camille Marie Fortinez, Andrew T Putz, et al.
RNA (New York, N.Y.)|March 7, 2023
Exploring the targeting spectrum of rocaglates among eIF4A homologsSai Kiran Naineni, Regina Cencic, Francis Robert, et al.
Nature Structural Biology|February 6, 2002
A pre-translocational intermediate in protein synthesis observed in crystals of enzymatically active 50S subunitsT Martin Schmeing, Amy C Seila, Jeffrey L Hansen, et al.
Nature|December 14, 2018
Trapping biosynthetic acyl-enzyme intermediates with encoded 2,3-diaminopropionic acidNicolas Huguenin-Dezot, Diego A Alonzo, Graham W Heberlig, et al.
Blood Advances|January 22, 2026
Molecular Features of Response and Resistance to Glofitamab, a T-Cell Engager for treatment of Large B-Cell LymphomaStephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Rocaglates as dual-targeting agents for experimental cerebral malariaDavid Langlais, Regina Cencic, Neda Moradin, et al.
Communications Biology|October 27, 2022
Evolution of naturally arising SARS-CoV-2 defective interfering particlesSamer Girgis, Zaikun Xu, Spyros Oikonomopoulos, et al.
Life Science Alliance|June 16, 2025
No evidence that human GIGYF2 interacts with GRB10: implications for human diseaseJung-Hyun Choi, Israel Shpilman, Niaz Mahmood, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Molecular Cell|April 17, 2007
The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosomeLori A Passmore, T Martin Schmeing, David Maag, et al.
Elife|February 18, 2025
Mechanisms of PP2A-Ankle2 dependent nuclear reassembly after mitosisJingjing Li, Xinyue Wang, Laia Jordana, et al.
Journal of the American Chemical Society|July 27, 2022
Structure and Function of a Dehydrating Condensation Domain in Nonribosomal Peptide BiosynthesisJon B Patteson, Camille Marie Fortinez, Andrew T Putz, et al.
RNA (New York, N.Y.)|March 7, 2023
Exploring the targeting spectrum of rocaglates among eIF4A homologsSai Kiran Naineni, Regina Cencic, Francis Robert, et al.
Nature Structural Biology|February 6, 2002
A pre-translocational intermediate in protein synthesis observed in crystals of enzymatically active 50S subunitsT Martin Schmeing, Amy C Seila, Jeffrey L Hansen, et al.
Nature|December 14, 2018
Trapping biosynthetic acyl-enzyme intermediates with encoded 2,3-diaminopropionic acidNicolas Huguenin-Dezot, Diego A Alonzo, Graham W Heberlig, et al.
Blood Advances|January 22, 2026
Molecular Features of Response and Resistance to Glofitamab, a T-Cell Engager for treatment of Large B-Cell LymphomaStephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Rocaglates as dual-targeting agents for experimental cerebral malariaDavid Langlais, Regina Cencic, Neda Moradin, et al.
Communications Biology|October 27, 2022
Evolution of naturally arising SARS-CoV-2 defective interfering particlesSamer Girgis, Zaikun Xu, Spyros Oikonomopoulos, et al.
Life Science Alliance|June 16, 2025
No evidence that human GIGYF2 interacts with GRB10: implications for human diseaseJung-Hyun Choi, Israel Shpilman, Niaz Mahmood, et al.
Pageof 11